The galU gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung

Infection and Immunity

Volumn 72, Issue 7, 2004, Pages 4224-4232

  Priebe, Gregory P ^a,b,d   Dean, Charles R ^c,e   Zaidi, Tanweer ^a   Meluleni, Gloria J ^a   Coleman, Fadie T ^a   Coutinho, Yamara S ^a   Noto, Michael J ^c   Urban, Teresa A ^c   Pier, Gerald B ^a   Goldberg, Joanna B ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d CHANNING LABORATORY   (United States)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; O ANTIGEN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL SECRETION; CYSTIC FIBROSIS; CYTOTOXICITY; FEMALE; GALU GENE; GENE DISRUPTION; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMAN CELL; KERATITIS; MORTALITY; MOUSE; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS AERUGINOSA PA103; PSEUDOMONAS AERUGINOSA PAO1; STRAIN DIFFERENCE; SYSTEMIC DISEASE; TYPE III SECRETION SYSTEM;

ANIMALS; CORNEA; EYE INFECTIONS, BACTERIAL; FEMALE; LUNG; MICE; MUTATION; PNEUMONIA; PSEUDOMONAS AERUGINOSA; UTP-GLUCOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; VIRULENCE;

EID: 3042640931     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.7.4224-4232.2004     Document Type: Article

References (62)

1. Alexandrakis, G., E. C. Alfonso, and D. Miller. 2000. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107:1497-1502.
2. Allewelt, M., F. T. Coleman, M. Grout, G. P. Priebe, and G. B. Pier. 2000. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect. Immun. 68:3998-4004.
3. Cannon, C. L., M. P. Kowalski, K. S. Stopak, and G. B. Pier. 2003. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am. J. Respir. Cell Mol. Biol. 29:188-197.
4. Chang, H. Y., J. H. Lee, W. L. Deng, T. F. Fu, and H. L. Peng. 1996. Virulence and outer membrane properties of a galU mutant of Klebsiella pneumoniae CG43. Microb. Pathog. 20:255-261.
5. Coleman, F. T., S. Mueschenborn, G. Meluleni, C. Ray, V. J. Carey, S. O. Vargas, C. L. Cannon, F. M. Ausubel, and G. B. Pier. 2003. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc. Natl. Acad. Sci. USA 100:1949-1954.
6. Comolli, J. C., L. L. Waite, K. E. Mostov, and J. N. Engel. 1999. Pili binding to asialo-GM1 on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa. Infect. Immun. 67:3207-3214.
7. Coyne, M. J., Jr., K. S. Russell, C. L. Coyle, and J. B. Goldberg. 1994. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J. Bacteriol. 176:3500-3507.
8. Cozens, A., M. Yezzi, K. Kunzelmann, T. Ohrui, L. Chin, K. Eng, W. Finkbeiner, J. Widdicombe, and D. Gruenert. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:38-47.
9. Cryz, S. J., Jr., T. L. Pitt, E. Fürer, and R. Germanier. 1984. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect. Immun. 44:508-513.
10. Dean, C. R., and J. B. Goldberg. 2002. Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant. FEMS Microbiol. Lett. 210:277-283.
11. Engels, W., J. Endert, M. A. Kamps, and C. P. van Boven. 1985. Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa. Infect. Immun. 49:182-189.
12. Evans, D., T. Kuo, M. Kwong, R. Van, and S. Fleiszig. 2002. Pseudomonas aeruginosa strains with lipopolysaccharide defects exhibit reduced intracellular viability after invasion of corneal epithelial cells. Exp. Eye Res. 75:635-643.
13. Finck-Barbancon, V., J. Goranson, L. Zhu, T. Sawa, J. P. Wiener-Kronish, S. M. Fleiszig, C. Wu, L. Mende-Mueller, and D. W. Frank. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557.
14. Fleiszig, S. M., J. P. Wiener-Kronish, H. Miyazaki, V. Vallas, K. E. Mostov, D. Kanada, T. Sawa, T. S. Yen, and D. W. Frank. 1997. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 65:579-586.
15. Frank, D. W. 1997. The exoenzyme S regulon of Pseudomonas aeruginosa. Mol. Microbiol. 26:621-629.
16. Goldberg, J. B., M. J. Coyne, Jr., A. N. Neely, and I. A. Holder. 1995. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect. Immun. 63:4166-4169.
17. Goldberg, J. B., W. L. Gorman, J. L. Flynn, and D. E. Ohman. 1993. A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species. J. Bacteriol. 175:1303-1308.
18. Hancock, R. E. W., L. M. Mutharia, L. Chan, R. P. Darveau, D. P. Speert, and G. B. Pier. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: A class of serum-sensitive, non-typeable strains deficient in lipopolysaccharide O side-chains. Infect. Immun. 42:170-177.
19. Hauser, A. R., E. Cobb, M. Bodi, D. Mariscal, J. Valles, J. N. Engel, and J. Rello. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30:521-528.
20. Hauser, A. R., S. Fleiszig, P. J. Kang, K. Mostov, and J. N. Engel. 1998. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells. Infect. Immun. 66:1413-1420.
21. Hazlett, L. D., and R. S. Berk. 1984. Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: Histopathological analysis. Infect. Immun. 43:783-790.
22. Jarrell, K., and A. M. Kropinski. 1977. The chemical composition of the lipopolysaccharide from Pseudomonas aeruginosa strain PAO and a spontaneously derived rough mutant. Microbios 19:103-116.
23. Koch, C., and N. Hoiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065-1069.
24. Kohler, H., S. P. Rodrigues, and B. A. McCormick. 2002. Shigella flexneri interactions with the basolateral membrane domain of polarized model intestinal epithelium: role of lipopolysaccharide in cell invasion and in activation of the mitogen-activated protein kinase ERK. Infect. Immun. 70:1150-1158.
25. Komeda, Y., T. Icho, and T. Iino. 1977. Effects of galU mutation on flagellar formation in Escherichia coli. J. Bacteriol. 129:908-915.
26. Krall, R., G. Schmidt, K. Aktories, and J. T. Barbieri. 2000. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect. Immun. 68:6066-6068.
27. Krall, R., J. Sun, K. J. Pederson, and J. T. Barbieri. 2002. In vivo Rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect. Immun. 70:360-367.
28. Kurahashi, K., O. Kajikawa, T. Sawa, M. Ohara, M. A. Gropper, D. W. Frank, T. R. Martin, and J. P. Wiener-Kronish. 1999. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J. Clin. Investig. 104:743-750.
29. Lee, E. J., B. A. Cowell, D. J. Evans, and S. M. J. Fleiszig. 2003. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Investig. Ophthalmol. Vis. Sci. 44:3892-3898.
30. Luzar, M. A., and T. C. Montie. 1985. Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa. Infect. Immun. 50:572-576.
31. Martin, H. G., J. R. Warren, and M. M. Dunn. 1989. The pulmonary clearance of smooth and rough strains of Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 140:206-210.
32. Nesper, J., C. M. Lauriano, K. E. Klose, D. Kapfhammer, A. Krai, and J. Reidl. 2001. Characterization of Vibrio cholerae O1 El Tor galU and galE mutants: Influence on lipopolysaccharide structure, colonization, and biofilm formation. Infect. Immun. 69:435-445.
33. Ohman, D. E., and A. M. Chakrabarty. 1982. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infect. Immun. 37:662-669.
34. Parad, R. B., C. J. Gerard, D. Zurakowski, D. P. Nichols, and G. B. Pier. 1999. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect. Immun. 67:4744-4750.
35. Pier, G. B., M. Grout, and T. S. Zaidi. 1997. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. USA 94:12088-12093.
36. Poggio, E. C., R. J. Glynn, O. D. Schein, J. M. Seddon, M. J. Shannon, V. A. Scardino, and K. R. Kenyon. 1989. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N. Engl. J. Med. 321:779-783.
37. Preston, M. J., S. M. Fleiszig, T. S. Zaidi, J. B. Goldberg, V. D. Shortridge, M. L. Vasil, and G. B. Pier. 1995. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect. Immun. 63:3497-3501.
38. Priebe, G. P., M. M. Brinig, K. Hatano, M. Grout, F. T. Coleman, G. B. Pier, and J. B. Goldberg. 2002. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine. Infect. Immun. 70:1507-1517.
39. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance Syst. Crit. Care Med. 27:887-892.
40. Rioux, S., C. Galarneau, J. Harel, J. Frey, J. Nicolet, M. Kobisch, J. D. Dubreuil, and M. Jacques. 1999. Isolation and characterization of mini-Tn10 lipopolysaccharide mutants of Actinobacillus pleuropneumoniae serotype 1. Can. J. Microbiol. 45:1017-1026.
41. Rivera, M., L. E. Bryan, R. E. Hancock, and E. J. McGroarty. 1988. Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: Analysis of lipopolysaccharide chain length. J. Bacteriol. 170:512-521.
42. Roy-Burman, A., R. H. Savel, S. Racine, B. L. Swanson, N. S. Revadigar, J. Fujimoto, T. Sawa, D. W. Frank, and J. P. Wiener-Kronish. 2001. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183:1767-1774.
43. Sandlin, R. C., K. A. Lampel, S. P. Keasler, M. B. Goldberg, A. L. Stolzer, and A. T. Maurelli. 1995. Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect. Immun. 63:229-237.
44. Sato, H., D. W. Frank, C. J. Hillard, J. B. Feix, R. R. Pankhaniya, K. Moriyama, V. Finck-Barbancon, A. Buchaklian, M. Lei, R. M. Long, J. Wiener-Kronish, and T. Sawa. 2003. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22:2959-2969.
45. Schroeder, T. H., M. M. Lee, P. W. Yacono, C. L. Cannon, A. A. Gerceker, D. E. Golan, and G. B. Pier. 2002. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappaB translocation. Proc. Natl. Acad. Sci. USA 99:6907-6912.
46. Schroeder, T. H., N. Reiniger, G. Meluleni, M. Grout, F. T. Coleman, and G. B. Pier. 2001. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J. Immunol. 166:7410-7418.
47. Schweizer, H. P. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109-121.
48. Schweizer, H. P. 1991. Improved broad-host-range lac-based plasmid vectors for the isolation and characterization of protein fusions in Pseudomonas aeruginosa. Gene 103:87-92.
49. Smith, R. S., M. C. Wolfgang, and S. Lory. 2004. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia. Infect. Immun. 72:1677-1684.
50. Song, Z., H. Wu, O. Ciofu, K.-F. Kong, N. Hoiby, J. Rygaard, A. Kharazmi, and K. Mathee. 2003. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection. J. Med. Microbiol. 52:731-740.
51. Sonoda, F., K. Oishi, H. Tanaka, M. Hideaki, S. Kobayashi, T. Nagatake, and K. Matsumoto. 1991. Serum sensitivity of Pseudomonas aeruginosa isolated from sputum as a virulence factor in the lower respiratory tract. Nihon Kyobu Shikkan Gakkai Zasshi 29:703-709.
52. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, and I. T. Paulsen. 2000. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406:959-964.
53. Tang, H. B., E. DiMango, R. Bryan, M. Gambello, B. H. Iglewski, J. B. Goldberg, and A. Prince. 1996. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64:37-43.
54. Wandersman, C., and S. Letoffe. 1993. Involvement of lipopolysaccharide in the secretion of Escherichia coli alpha-haemolysin and Erwinia chrysanthemi proteases. Mol. Microbiol. 7:141-150.
55. Wilkinson, S. G. 1983. Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa. Rev. Infect. Dis. 5(Suppl. 5):S941-S947.
56. Worlitzsch, D., R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K. C. Meyer, P. Birrer, G. Bellon, J. Berger, T. Weiss, K. Botzenhart, J. R. Yankaskas, S. Randell, R. C. Boucher, and G. Doering. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Investig. 109:317-325.
57. Yahr, T. L., L. M. Mende-Mueller, M. B. Friese, and D. W. Frank. 1997. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J. Bacteriol. 179:7165-7168.
58. Yahr, T. L., A. J. Vallis, M. K. Hancock, J. T. Barbieri, and D. W. Frank. 1998. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. USA 95:13899-13904.
59. Zaidi, T. S., S. M. Fleiszig, M. J. Preston, J. B. Goldberg, and G. B. Pier. 1996. Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 37:976-986.
60. Zaidi, T. S., S. M. J. Fleiszig, M. Preston, J. B. Goldberg, and G. B. Pier. 1995. Pathogenesis of Pseudomonas aeruginosa ulcerative keratitis: Role of bacterial lipopolysaccharide (LPS) in invasion of corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 36:S1020.
61. Zaidi, T. S., J. Lyczak, M. Preston, and G. B. Pier. 1999. Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis. Infect. Immun. 67:1481-1492.
62. Zielinski, N. A., A. M. Chakrabarty, and A. Berry. 1991. Characterization and regulation of the Pseudomonas aeruginosa algC gene encoding phosphomannomutase. J. Biol. Chem. 266:9754-9763.